Adam Runions is a researcher in the Department of Computer Science at the University of Calgary, leading the MPG Partner Group in computational analysis of leaf development through collaborative work with Miltos Tsiantis. His group is embedded in the Graphics Cluster, focusing on interdisciplinary problems at the intersection of computer science and developmental biology. University of Calgary - Department of Computer Science MPG Partner Group (2022) Graphics Cluster affiliation His research explores computational modeling and analysis of plant form and development across multiple scales, integrating geometric modeling, physically-based simulation, and computer-aided design. Key themes include plant morphogenesis, self-organization of natural forms, and cross-disciplinary applications in computer graphics and animation. Recent publications emphasize plant development (leaf shape, bark patterning), mathematical modeling (auxin-driven patterning), and geometric techniques (subdivision surfaces, PUPs). Collaborations span institutions like the Max Planck Institute for Plant Breeding Research. Scientific Awards Marie Sklodowska-Curie Fellowship Best Paper Award (International Conference on Cyberworlds 2015) Best Student Paper Award (Computer Graphics International 2011) The group actively recruits BSc, MSc, and PhD students with backgrounds in computer science and mathematics for projects on plant form simulation and digital content creation. Research integrates evolutionary biology, biomechanical modeling, and computational techniques.
Wojciech Matusik is a Professor of Electrical Engineering and Computer Science at MIT's Computer Science and Artificial Intelligence Laboratory (CSAIL). He leads the Computational Design and Fabrication Group and is a member of the Computer Graphics Group. His research spans computer graphics, robotics, and AI-driven manufacturing, with a focus on computational design, tactile sensing, and material science. Matusik holds a PhD in Computer Science from MIT (2003), an MS from MIT (2001), and a BS from UC Berkeley (1997). His work includes groundbreaking projects like differentiable cloth simulation (DiffCloth), AI-enhanced molecular design, and tactile sensing gloves. He has received prestigious awards such as the MIT TR35 (2004), DARPA Young Faculty Award (2012), and Ruth and Joel Spira Teaching Award (2014). Matusik teaches courses on computer graphics, machine learning, and computational fabrication at MIT. Key research themes include: Robotics: Robotic assembly, tactile interaction, and soft robotics Graphics: 3D holography, procedural material generation Manufacturing: Additive fabrication, topology optimization His recent articles explore AI-driven molecular synthesis, holographic displays, and tactile-enabled VR systems. Matusik collaborates on open-source tools like the WiReSens tactile platform and Simit language for sparse systems.
Michael McAlpine is a Professor in the Mechanical Engineering department at the University of Minnesota . He also holds affiliations with the Biomedical Engineering and Electrical and Computer Engineering departments. His research focuses on 3D printing functional materials & devices , Nanoscale inks , Biomedical devices , Bioelectronics , and Flexible Microsystems . Research Interests : 3D Printing, Biomedical Engineering, Nanotechnology, Flexible Electronics, Microfluidics Labs : ME 361/363 Contact : mcalpine@umn.edu , (612) 626-3303, ME 117 Recent Research Trends include 3D Printed Biomedical Devices , Flexible Electronics , and Bioprinting Applications . His work spans from Spinal Organoid Formation to Programmable Drug Release Capsules . Scientific Award : Circulation Research 2020 Best Manuscript Award
Connor Coley is the Henri Slezynger (1957) Career Development Assistant Professor at the Massachusetts Institute of Technology (MIT) School of Engineering. His research bridges chemistry and machine learning, focusing on autonomous molecular discovery, predictive chemistry, and laboratory automation. Education: Ph.D., MIT (2019) M.S.CEP., MIT (2016) B.S., Caltech (2014) Research Interests: Dr. Coley’s work centers on domain-informed machine learning for chemistry, computer-aided molecular design, and autonomous laboratories. Key themes include predictive modeling of chemical reactivity, optimization of synthesis pathways, and integration of AI with experimental data for drug discovery and materials science. Publications: His recent articles highlight advancements in AI-driven reaction prediction, molecular representation learning, and laboratory automation. Trends include applications of Bayesian optimization, contrastive learning, and diffusion models to chemical discovery. Scientific Awards: Camille Dreyfus Teacher-Scholar Award (2025) James W. Swan Outstanding Faculty (2025) Schmidt Futures AI2050 Early Career Fellow (2022) NSF CAREER Award (2021) Forbes 30 Under 30: Healthcare (2019) Software & Tools: He leads the open-source ASKCOS software suite for synthesis planning, adopted by 35,000+ chemists and deployed at 15+ pharmaceutical companies. His team also develops tools for metabolomics and molecular representation learning.
Prof. Dr. André Bardow is a Full Professor in Energy and Process Systems Engineering at ETH Zurich , leading research at the intersection of thermodynamics, machine learning, and sustainable energy systems. Previously, he held professorships at RWTH Aachen University (2010-2020) and TU Delft (2007-2010). He also served as part-time director at Forschungszentrum Jülich (2017-2022) and visiting professor at UC Santa Barbara (2015/16). His work focuses on energy systems optimization , computer-aided molecular design , and CO2 capture & utilization . PhD from RWTH Aachen University Current ETH Zurich affiliation Former roles at RWTH Aachen, TU Delft, Jülich Research Center His research integrates machine learning with thermodynamic modeling to optimize processes like crystallization and electrochemical cooling . Recent publications demonstrate advancements in solvent design, CO2 transport LCA, and ORC working fluid optimization. He chairs the VDI Technical Committee for Thermodynamics (2016-2024) and has received multiple awards including the Covestro Science Award and Arnold-Eucken-Award . Current projects address carbon circular economies , electrified chemical production , and AI-driven process optimization . His lab at ETH Zurich develops cutting-edge technologies like ML-CAMPD frameworks for sustainable separation processes and photoacid-based CO2 capture systems. Funding from the H2020 Systemic Expansion of Circular Ecosystems (grant 101036854) supports these initiatives. 2024 Clarivate Highly Cited Researcher 2022 Inaugural Lecture: "To sustainability and beyond: A computer-animated story on energy & chemicals" Recipient of multiple teaching and research excellence awards
Levent Burak Kara is a Professor in the Department of Mechanical Engineering at Carnegie Mellon University (CMU), with a courtesy appointment in the Robotics Institute. He is a leading researcher in AI-driven computational design, additive manufacturing, and intelligent engineering systems, leading the Visual Design and Engineering Lab (VDEL) at CMU. Education: B.S., Mechanical Engineering, Middle East Technical University (1998) M.S., Mechanical Engineering, Carnegie Mellon University (2000) Ph.D., Mechanical Engineering, Carnegie Mellon University (2005) His research focuses on integrating machine learning, optimization, and geometric modeling to revolutionize engineering design and manufacturing. Key areas include topology optimization, CAD intelligence, digital twins, generative design, bioengineering, and electronic design automation. His work enables automation of traditionally labor-intensive design processes using deep learning and reinforcement learning. His recent publications reveal a strong trend toward physics-informed surrogate modeling, real-time simulation, manufacturability prediction, and AI-driven automation in mechanical, biomedical, and electronic systems. These works frequently appear in top journals such as Journal of Mechanical Design and Journal of Applied Mechanics , and at premier conferences like NeurIPS and DAC. Scientific Awards: National Science Foundation CAREER Award ASME Design Automation Society Young Investigator Award Google AI for Social Good Impact Scholar Kara advises several Ph.D. students and has secured significant funding from federal agencies such as the NSF and the U.S. Army Research Laboratory, as well as collaborations with industrial leaders including Cadence Design Systems and NVIDIA. His research is also supported by CMU’s NextManufacturing Center and the Critical Technology Initiative. He is actively involved in developing intelligent design systems that leverage AI to automate product design, optimize manufacturing processes, and improve medical diagnostics, particularly in oral cancer screening and organ preservation. His lab, VDEL, is a hub for innovation in AI-enabled engineering.
Senior Lecturer Outi Salo-Ahen is affiliated with Åbo Akademi University's Faculty of Natural Sciences and Engineering , Department of Pharmacy. Her research focuses on computational pharmacology, drug design, and pharmaceutical chemistry, particularly targeting chemokine receptors (CCR5/CXCR4) and transient receptor potential channels (TRPA1) for therapeutic applications. Doctor of Pharmacy (2006, University of Kuopio/UEF) MSc in Pharmaceutical Chemistry (2001, UEF) BSc in Pharmacy (1999, UEF) University Pedagogy Modules 1-5 (2012-2015) Her work contributes to UN Sustainable Development Goals through education and pharmaceutical innovation . Recent research trends include: Antimicrobial resistance solutions TRPA1 channel modulation Nanotechnology-enabled drug delivery Multi-target HIV-1 inhibitors 3D printing of biocompatible materials Computational analysis of nucleic acid frameworks She actively supervises doctoral projects, serves on assessment panels, and leads collaborations like Nordic Pharmaceutical Translation and Innovation. Her 60+ publications demonstrate expertise in molecular modeling and drug discovery.
André Bardow is a Full Professor at the Department of Mechanical and Process Engineering, ETH Zürich. His research focuses on energy systems optimization, life cycle assessment, computer-aided molecular design, and CO2 capture/utilization. Professor (ETH Zürich, 2020–present) Head of Institute of Technical Thermodynamics (RWTH Aachen University, 2010–2020) Visiting Professor (University of California, Santa Barbara, 2015/16) Part-time Director (Forschungszentrum Jülich, 2017–2022) Associate Professor (TU Delft, 2007–2010) Research Interests: His work spans energy and process systems engineering, with emphasis on sustainable technologies. Key areas include: Computer-aided molecular and process design Machine learning for chemical engineering Carbon capture and utilization (CCU) Life cycle assessment (LCA) of industrial processes Thermo-economic modeling of energy systems Multiphase equilibrium analysis Publication Trends: Recent articles focus on integrating machine learning with process design, optimizing CO2 capture in steel production, and advancing electrochemical cooling technologies. Subfields include sustainable plastics, ORC working fluids, and solvent mixture design. Scientific Awards: Fellow of the Royal Chemical Society Recent Innovative Contribution Award (EFCE, 2019) PSE Model-Based Innovation Prize (2018) Covestro Science Award (first recipient) Arnold-Eucken-Award (VDI-GVC) Highly Cited Researcher (Clarivate, 2024) Advising and Grants: Professor Bardow mentors students in process optimization and leads projects like Systemic expansion of territorial CIRCULAR Ecosystems for end-of-life FOAM (Grant 101036854, EC).
Ping He is a Professor in the Department of Molecular, Cellular, and Developmental Biology (MCDB) at the University of Michigan in Ann Arbor. His research focuses on plant immunity mechanisms, particularly using Arabidopsis as a model system to study pathogen defense activation, signaling pathways, and the interplay between immunity and environmental stress responses. He also leads the Molecular, Plant-Microbe Interaction Laboratory, applying interdisciplinary approaches (genetics, biochemistry, cellular biology) to enhance crop resilience through foundational plant science discoveries. His work bridges plant biology and computational biology, with recent contributions to AI-driven medical imaging applications such as bladder cancer treatment response assessment, lung cancer early detection, and breast tomosynthesis denoising. These efforts emphasize integrating machine learning into clinical workflows and establishing best practices for AI in healthcare. Research Highlights: Plant immunity signaling and environmental stress crosstalk Radiomics and deep learning for cancer diagnosis/prognosis AI model validation and multi-institutional clinical trials Medical imaging artifact correction (e.g., motion blur, noise) Publications emphasize AI applications in oncology imaging, radiologist decision support systems, and multimodal data fusion. He has contributed to AAPM task group guidelines for AI in computer-aided diagnosis and advocates for rigorous quality assurance frameworks in medical AI deployment.
Azad J Naeemi is a Professor holding the Dean's Professorship in the School of Electrical and Computer Engineering at the Georgia Institute of Technology. He serves as Editor-in-Chief of the IEEE Journal on Exploratory Computational Devices and Circuits and Associate Director for Computation of the NSF-supported National Nanotechnology Coordinated Infrastructure (NNCI). His educational background includes a B.S. in Electrical Engineering from Sharif University (1994) and M.S./Ph.D. in Electrical and Computer Engineering from Georgia Tech (2001/2003). Prior to academia, he worked as a design engineer in Tehran (1994-1999) and as a research engineer at Georgia Tech's Microelectronics Research Center (2004-2008). Professor Naeemi's research spans nanotechnology with focus on emerging nanoelectronic devices, spintronics, ferroelectric devices, and design technology co-optimization for CMOS/beyond-CMOS technologies. His work bridges materials, devices, circuits, and systems, particularly investigating integrated circuits based on nanoscale devices and interconnects. Educational research includes experiential learning environments for engineering education. Recent publications (2024-2025) demonstrate strong emphasis on spin-orbit torque MRAM, ternary content addressable memories, ferroelectric/antiferroelectric devices, and plasmonic circuits. Key trends include energy-efficient hardware accelerators, neuromorphic computing applications, and compact modeling for advanced technology nodes. His scientific honors include: IEEE Solid-State Circuits Society James Meindl Innovators Award (2022) IEEE Electron Devices Society Paul Rappaport Award (2008) NSF CAREER Award (2013) SRC Inventor Recognition Award (2010) Multiple Georgia Tech teaching awards Professor Naeemi leads research supported by NSF (including NNCI infrastructure) and SRC. His editorial role with IEEE JXCDC positions him at the forefront of exploratory computational devices. He previously served as General Co-Chair for the IEEE International Interconnect Technology Conference (2013). His work connects with Georgia Tech's Microelectronics Research Center and national nanotechnology initiatives through the NNCI network, focusing on computational infrastructure for nanoscale device characterization and design.
Kamal Sen is an Associate Professor in the Department of Biomedical Engineering at Boston University, serving as Director of the Natural Sounds and Neural Coding Laboratory and Director of Admissions and Recruitment for Master’s Programs. He holds a PhD and MA in Physics from Brandeis University and a BA in Physics from Bates College. His research focuses on understanding how neurons encode natural sounds, particularly in the auditory cortex. Key areas include neural coding efficiency, hierarchical auditory processing, and the role of learning in shaping receptive fields. He developed the BOSSA algorithm to address sound segregation challenges in noisy environments, with applications for hearing aid technology. Sen’s work integrates electrophysiological techniques with theoretical approaches from signal processing, information theory, and systems theory. His lab explores neural discrimination of behaviorally relevant sounds and models cortical processing dynamics using computational frameworks. Recent studies investigate parvalbumin neuron contributions to temporal coding and cortical noise reduction in complex auditory scenes. His publications span neural circuit modeling, fNIRS applications in BCI, and biomimetic algorithms for auditory scene analysis. Research highlights include exploring schizophrenia-related gene effects on neural circuits and developing 3D neurosphere models for Parkinson’s disease.
Pingfu Fu, PhD, is a Professor in the Department of Population and Quantitative Health Sciences at Case Western Reserve University's School of Medicine. He is also a member of the Developmental Therapeutics Program at the Case Comprehensive Cancer Center. His expertise spans biostatistics, mathematics, and computer science, with a focus on cancer research and HIV/AIDS. Dr. Fu advises researchers on study design and statistical methodology for clinical and pre-clinical studies. He teaches courses in survival data analysis and clinical trials, and was recognized as 'Professor of the Year' in 2010 by the Department of Epidemiology and Biostatistics. Education: PhD in Biostatistics (Case Western Reserve University, 2001), MS in Statistics (Case Western Reserve University, 1996), MS in Mathematics (Xiangtan University, 1988), and BS in Mathematics (Jiangxi Normal University, 1984). His research interests include survival analysis, tree-based methods, clinical trials, and statistical applications in medical research. He has co-authored numerous peer-reviewed articles, focusing on cancer disparities, radiomics, and computational pathology. Professional memberships include the American Statistical Association, American Mathematical Society, and American Cancer Society. Dr. Fu holds editorial roles at Reviews on Recent Clinical Trials , Journal of Clinical Oncology , and Journal of the National Cancer Center . His work has addressed mathematical challenges in stochastic processes and resolved statistical issues in study design and tree-based models. Notable contributions include developing risk prediction models for cancer outcomes and advancing interdisciplinary collaborations across oncology, biostatistics, and computer science. His lab focuses on integrating computational methods with clinical data to improve patient outcomes.
Dr. Ed E. Moret is an Associate Professor of Computational Medicinal Chemistry at Utrecht University, where he serves as Managing Director of the Utrecht Institute for Pharmaceutical Sciences. He is a member of the Departmental Executive Board and Chair of the Board of Examiners of the School of Pharmacy. His academic career spans over three decades with significant contributions to pharmaceutical sciences. Utrecht University, Utrecht Institute for Pharmaceutical Sciences School of Pharmacy, Department of Chemical Biology and Drug Discovery Managing Director since January 2010 Dr. Moret's educational background includes completing Gymnasium-b at Gymnasium Camphusianum in Gorinchem in 1979, followed by pharmacy studies at Utrecht University until 1988. He earned his PhD in 1993 with research on calculations and simulations of DNA-alkylating cytostatics under supervision of Prof. L.H.M. Janssen and Prof. J.P.A.E. Tollenaere. He also conducted postdoctoral research at the Scripps Research Institute with Prof. A.J. Olson. His primary research interests focus on molecular recognition, particularly in auto-immune diseases, with expertise spanning computational medicinal chemistry, computer-aided drug discovery, cheminformatics, and bioinformatics. Dr. Moret's work bridges the gap between theoretical calculations and experimental validation in drug design. His research portfolio demonstrates a consistent trajectory from fundamental molecular interactions to applied drug discovery, with particular emphasis on enzyme inhibitors, carbohydrate-protein interactions, and molecular recognition processes. Analysis of his publication record reveals a strong focus on structure-based drug design, with significant contributions to the development of inhibitors for enzymes like β-glucocerebrosidase, NNMT, and neuraminidase. His work spans multiple therapeutic areas including lysosomal storage disorders, cancer metabolism, and infectious diseases. The interdisciplinary nature of his research is evident in the integration of computational approaches with experimental validation across biochemistry, pharmacology, and medicinal chemistry. Teacher of the Year (awarded three times by Pharmacy students) Member of editorial boards for Medicines and Conceptuur journals Secretary of Board of FIGON (2016) Secretary of Raad voor de Farmaceutische Wetenschappen (2024) Member of Board of Stichting Farmaceutische Erfgoed (2024) Dr. Moret has been actively involved in educational innovation, developing and coordinating the master's programme Drug Innovation, the profile Drug Regulatory Sciences, and the Honours programme Pharmaceutical Sciences. He has taught courses for pharmacy, chemistry, UCU and medical sciences students, as well as PhD courses in bioinformatics and computer-aided drug discovery. His educational contributions include developing an inquiry-based elective course on drug discovery, for which he published educational research. He holds BKO and SKO teaching qualifications and participated in the Centre of Excellence in University Teaching program. As Managing Director of the Utrecht Institute for Pharmaceutical Sciences, Dr. Moret leads research initiatives across chemical biology, drug discovery, and pharmaceutical sciences. His leadership extends to multiple advisory and editorial roles within the pharmaceutical research community, reflecting his significant contributions to both academic and professional spheres of pharmaceutical sciences.
Antti Poso is a Professor of Drug Design at the University of Eastern Finland (Kuopio), affiliated with the School of Pharmacy under the Faculty of Health Sciences. His research focuses on computer-aided molecular design, particularly targeting anti-cancer drugs and anti-microbials. Key projects include the EDCMET project (2019–2024) and the GeneCellNano Flagship (2020–2028). He leads the Molecular Modeling and Drug Design Research Group, specializing in QSAR analysis, kinase inhibition profiling, and systems-level drug response modeling. Recent work includes studies on SARS-CoV-2 inhibitors, endocrine disruptors, and bacterial pathogenesis. His findings bridge chemical structure with biological outcomes, leveraging computational tools like CCA and molecular dynamics simulations. Collaborations span medicinal chemistry, pharmacology, and systems biology, contributing to both academic and applied drug discovery efforts. Education: Not explicitly stated in texts; assumed to hold advanced degrees in pharmacy or chemistry. Research Themes: Drug design, molecular modeling, QSAR, computational biology, and anti-infective agents. Key Contributions: Over 150+ publications, including influential works on chemoinformatics-driven drug response analysis and structure-based inhibitor design. Publications highlight advancements in kinase inhibitors, anti-microbial strategies, and viral hijacking mechanisms. His work emphasizes translating computational insights into therapeutic solutions for cancer, infectious diseases, and metabolic disorders.
Pia Vogel is a Professor in the Department of Biological Sciences at Southern Methodist University (SMU), where she leads research on nucleotide-binding proteins using Electron Spin Resonance spectroscopy and molecular modeling. Her work focuses on elucidating structural mechanisms in ATP synthase, multidrug resistance transporters, and calcium channels with biomedical applications in cancer therapy and neurodegenerative diseases. Education: Ph.D., University of Kaiserlautern Dr. Vogel's research program investigates three interconnected domains: the rotary mechanics of FoF1-ATP synthase (particularly the external stalk subunit b-dimer), the structural basis of multidrug resistance in P-glycoprotein and MRPs, and ATP-regulated calcium release via ryanodine receptors. Her laboratory employs site-specific spin labeling, ESR spectroscopy, and computational modeling to resolve protein dynamics and interactions at molecular resolution, contributing to understanding energy transduction in ATP synthase and mechanisms of drug resistance. Analysis of her 15 most recent publications (2020-2025) reveals a dominant focus on developing and characterizing P-glycoprotein and BCRP inhibitors to overcome chemotherapy resistance in cancer. These studies integrate computational screening, ATPase assays, and cell-based models to evaluate inhibitor efficacy, with emerging applications in Alzheimer's research through amyloid-β transport studies. The work demonstrates consistent methodological synergy between biophysical characterization and therapeutic development. Dr. Vogel maintains an active research group supported by sustained funding, evidenced by continuous publication output and laboratory infrastructure. Her team employs multidisciplinary approaches spanning biophysics, biochemistry, and computational biology to address fundamental questions in membrane protein function. Her laboratory facilities in DLSB 221 include specialized Electron Spin Resonance instrumentation and dual Linux computing clusters for molecular dynamics simulations. The research environment supports collaborative projects extending her work into cancer therapeutics and neurodegenerative disease mechanisms through partnerships with clinical and computational researchers.
